[HTML][HTML] COVID-19 and lung cancer survival: an updated systematic review and meta-analysis

S Oldani, F Petrelli, G Dognini, K Borgonovo, MC Parati… - Cancers, 2022 - mdpi.com
Simple Summary The coronavirus disease (COVID-19) pandemic has increased morbidity
and mortality in the general population. Patients with cancer have immune dysfunction due …

[HTML][HTML] Risk factors for mortality among lung cancer patients with covid-19 infection: A systematic review and meta-analysis

M Wu, S Liu, C Wang, Y Wu, J Liu - Plos one, 2023 - journals.plos.org
Background Lung cancer patients with coronavirus disease 2019 (COVID-19) infection
experience high mortality rates. The study aims to determine the risk factors for mortality in …

[HTML][HTML] Cancers and COVID-19 risk: a Mendelian randomization study

Z Li, Y Wei, G Zhu, M Wang, L Zhang - Cancers, 2022 - mdpi.com
Simple Summary During the COVID-19 pandemic, cancer patients are regarded as a highly
vulnerable population. Given the unavoidable bias and unmeasured confounders in …

[HTML][HTML] Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis

L Wang, Y Wang, X Cheng, X Li, J Li - Translational Oncology, 2023 - Elsevier
Background The coronavirus disease 2019 (COVID-19) pandemic poses a great challenge
to the treatment of lung cancer patients. Materials and methods The PubMed, Embase, and …

[HTML][HTML] The intriguing thyroid hormones–lung cancer association as exemplification of the thyroid hormones–cancer association: Three decades of evolving research

MV Deligiorgi, DT Trafalis - International journal of molecular sciences, 2021 - mdpi.com
Exemplifying the long-pursued thyroid hormones (TH)–cancer association, the TH–lung
cancer association is a compelling, yet elusive, issue. The present narrative review provides …

[HTML][HTML] Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicentre real-life cohort study

S Priou, G Lamé, G Zalcman, M Wislez, R Bey… - European Journal of …, 2022 - Elsevier
Abstract Introduction The SARS-CoV-2 pandemic has impacted the care of cancer patients.
This study sought to assess the pandemic's impact on the clinical presentations and …

Impact of the COVID‐19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study

E Guével, S Priou, G Lamé, J Wassermann… - Cancer …, 2023 - Wiley Online Library
Abstract Background The SARS CoV‐2 pandemic disrupted healthcare systems. We
compared the cancer stage for new breast cancers (BCs) before and during the pandemic …

Electrodynamic therapy: Novel nanodynamic strategy for anticancer and anti-infection therapy

W Liu, N Wu, J Song, L Xie, J Zhang, J Liu… - Chemical Engineering …, 2024 - Elsevier
Nanodynamic therapy (NDT) as an effective candidate strategy has made great
achievements in the treatment of tumors, bacterial infections and other related diseases …

[HTML][HTML] A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers

U Janzic, U Bidovec-Stojkovic, P Korosec, K Mohorcic… - Vaccines, 2023 - mdpi.com
Background: The recommended booster third dose of vaccination against COVID-19 in
cancer patients seems reasonable to protect them against a severe disease course. A …

[HTML][HTML] Effect of Obesity among Hospitalized Cancer Patients with or without COVID-19 on a National Level

J Cottenet, S Tapia, P Arveux, A Bernard… - Cancers, 2022 - mdpi.com
Simple Summary Few papers have looked for an association between obesity and mortality
risk in cancer patients with COVID-19 but, to our knowledge, none have studied this …